Sun, Dec 28, 2014, 11:03 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • fgnoms fgnoms Mar 7, 2007 5:31 AM Flag

    In today's UK Independent newspaper

     

    Market Report: Shire's New River bid could still be contested
    By Andrew Dewson
    Published: 07 March 2007
    It looks like shareholders at Shire Pharmaceuticals are busy counting their chickens over the acquisition of New River Pharmaceuticals. The tender document was released on Friday and most investors and analysts have written off the possibility of a counter bid.

    However, not everyone is convinced. At least four other pharmaceutical groups were interested in New River and had the company's Vyvanse attention deficit disorder treatment been approved as expected in December the chances are that Shire would not have been the sole bidder.

    One trader said that although Randall Kirk, New River's founder, has pledged his 50.2 per cent stake in the company to Shire there is nothing stopping a counter bidder making an unsolicited approach. He said: "Shire's bid is a sitting duck waiting to be shot at." Shire climbed 24p to 1,089p as the broker UBS reiterated its 1,250p price target.

    This topic is deleted.
 
SHPG
212.88+3.59(+1.72%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.